14 completed, 3 active not recruiting, 2 terminated, 2 withdrawn. 11 Not applicable, 4 Phase 2, 3 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 6, Active not recruiting 2, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 2, Terminated 2 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Neuropathy, Painful: new trials by email Literature Review of Neuropathy, Painful trials Research Report on Neuropathy, Painful
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combined Circulatory and Dietary Interventions for Neuropathy INF® Therapy, NVIf - Diabete Type 2, Neuropathy, Painful | Not applicable | Withdrawn | Loma Linda University | 2026-10-01 | 2026-11-10 | |
| Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT) Peripheral Neuropathy, Painful Neuropathy | Active not recruiting | Weill Cornell Medical College in Qatar | 150 | 2025-05-11 | 2025-09-09 | |
| Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation Somatosensory feedback - Neuropathy;Peripheral, Neuropathy, Diabetic | Not applicable | Unknown | Institute Mihajlo Pupin | 20 | 2024-06-13 | 2024-06-24 |
| MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts VR+TENS - Neuropathy, Neuropathy, Painful | Not applicable | Recruiting | ETH Zurich | 40 | 2022-06-30 | 2024-11-18 |
| Methylglyoxal Evaluation in Humans Type 2 Diabetes, Neuropathy, Painful | Completed | University of Kansas Medical Center | 39 | 2022-05-02 | 2025-04-04 | |
| Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain Erchonia® EVRL™, Placebo Laser - Neuropathy, Diabetic, Neuropathy;Peripheral | Not applicable | Completed | Erchonia Corporation | 64 | 2022-02-17 | 2025-08-13 |
| The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) Yoga, Education control, Usual care - Chemotherapy-induced Peripheral Neuropathy, Nerve Pain | Not applicable | Active not recruiting | Dana-Farber Cancer Institute | 227 | 2021-10-29 | 2026-09-22 |
| The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) Electroacupuncture, Sham Acupuncture - Chemotherapy-induced Peripheral Neuropathy, Nerve Pain | Not applicable | Active not recruiting | Dana-Farber Cancer Institute | 255 | 2021-05-21 | 2026-11-17 |
| Veteran Ear Acupuncture Pilot Project Self-administration of auricular acupuncture without prosthesis, Self-administration of auricular acupuncture with prosthesis - Chronic Pain Syndrome, Pain | Not applicable | Completed | Chillicothe VA Medical Center | 12 | 2020-02-27 | 2021-11-01 |
| Methods of Early Detection and Grading Of Diabetic Peripheral Neuropathy (MEDON) Perception Threshold Tracking (PTT), Axon-flair mediated respons, Heart rate variability - Neuropathy, Diabetic, Neuropathy, Painful | Completed | Aalborg University Hospital | 80 | 2019-08-12 | 2021-11-02 | |
| The Effect of Lacosamide in Peripheral Neuropathic Pain Lacosamide, Placebo - Neuropathic Pain, Neuropathy;Peripheral | Phase 2 | Terminated | Danish Pain Research Center | 63 | 2019-01-15 | 2023-02-16 |
| Vitamin B12 Supplementation in Diabetic Neuropathy B12 fix 1000mcg, Placebo - Diabetes Mellitus, Diabetic Neuropathies | Not applicable | Completed | Aristotle University Of Thessaloniki | 90 | 2018-02-01 | 2021-01-12 |
| Lidocaine for Oxaliplatin-induced Neuropathy Lidocaine Hydrochloride, Placebo, FOLFOX regimen - Neuropathy, Painful, Chemotherapy-induced Peripheral Neuropathy | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 26 | 2017-09-15 | 2022-03-09 |
| Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain Mindfulness-Based Stress Reduction (MBSR) - Cancer, Painful Neuropathy | Not applicable | Completed | Ottawa Hospital Research Institute | 120 | 2016-07-01 | 2020-11-30 |
| Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy Intravenous Immunoglobulin, Placebo - Small Fiber Neuropathy | Phase 2 | Completed | Academisch Ziekenhuis Maastricht | 60 | 2016-07-01 | 2019-07-05 |
| DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain Quantitative sensory testing (QST) - Neuropathic Pain | Completed | University of Kiel | 1550 | 2015-06-01 | 2022-11-08 | |
| Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy Lacosamide, Placebo - Small Fiber Neuropathy | Phase 3 | Completed | Academisch Ziekenhuis Maastricht | 25 | 2014-09-01 | 2018-01-10 |
| Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy Ziconotide, placebo - Painful Myelopathy, Painful Neuropathy | Phase 4 | Withdrawn | Aaron Boster | 2014-01-01 | 2018-09-18 | |
| The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain Mindfulness-Based Stress Reduction - Breast Cancer, Painful Neuropathy | Not applicable | Completed | Ottawa Hospital Research Institute | 118 | 2013-10-01 | 2019-07-23 |
| Study of Sulfasalazine in Treating Painful Neuropathy Sulfasalazine, placebo - Painful Neuropathy | Phase 2 | Terminated | Massachusetts General Hospital | 8 | 2013-05-01 | 2018-08-22 |
Showing 20 of 23. Sign in to see all of them.
Diabetic Neuropathies (7) · Neuralgia (7) · Chronic Pain (6) · Pain (6) · Diabetes Mellitus (5) · Neuritis (3) · Peripheral Nervous System Diseases (3) · Agnosia (2) · Diabetes Mellitus, Type 2 (2) · Low Back Pain (2) · Small Fiber Neuropathy (2) · Back Pain (1) · Breast Neoplasms (1) · Cold Hypersensitivity (1)
Nervous System Diseases (16) · Neuromuscular Diseases (16) · Peripheral Nervous System Diseases (13) · Endocrine System Diseases (11) · Pathological Conditions, Signs and Symptoms (11) · Neurologic Manifestations (10) · Signs and Symptoms (10) · Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Diabetes Complications (6) · Diabetes Mellitus (6) · Pain (4) · Musculoskeletal Diseases (3) · Neoplasms (2)
Duloxetine Hydrochloride (2) · Lacosamide (2) · Mindfulness-Based Stress Reduction (2) · Electroacupuncture (1) · Folfox protocol (1) · Immunoglobulins, Intravenous (1) · Laser-Doppler Flowmetry (1) · Lidocaine (1) · Magnetic Resonance Imaging (1) · Prostheses and Implants (1) · Sodium Chloride (1) · Sulfasalazine (1) · Vitamin B 12 (1) · Yoga (1) · microcrystalline cellulose (1)
Academisch Ziekenhuis Maastricht (2) · Dana-Farber Cancer Institute (2) · Ottawa Hospital Research Institute (2) · Aalborg University Hospital (1) · Aaron Boster (1) · Aristotle University Of Thessaloniki (1) · BioDelivery Sciences International (1) · Chillicothe VA Medical Center (1) · Danish Pain Research Center (1) · ETH Zurich (1) · Eli Lilly and Company (1) · Erchonia Corporation (1) · Institute Mihajlo Pupin (1) · Loma Linda University (1) · Massachusetts General Hospital (1)
United States (11) · Canada (2) · Denmark (2) · Netherlands (2) · Germany (1) · Greece (1) · Israel (1) · Qatar (1) · Serbia (1) · Switzerland (1)
Catharina G Faber, MD, PhD (2) · Aaron L Boster, MD (1) · Andrew Finn, PharmD (1) · Brian J Wainger, MD, PhD (1) · Brian L James, MD (1) · David Bennett, Prof. (1) · David Yarnitsky, PhD (1) · Doug Wright, PhD (1) · Kyan Sahba, PhD (1) · Nanna B Finnerup, Professor (1) · Patricia Poulin, Ph.D (1) · Patricia Poulin, PhD (1) · Professor Rayaz A. Malik, PhD (1)
PMID 17327338, PMID 22480803, PMID 26032776, PMID 27363506, PMID 27439408, PMID 30649227, PMID 31604475, PMID 33766992, PMID 35003503, PMID 36130086, PMID 36825610, PMID 38968400, PMID 40987057, PMID 41246983, PMID 42860829
2015 (1), 2018 (1), R01CA251470 (1)